尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Andrade, Robert Christopher. Officer active across 1 company, notably Fennec Pharmaceuticals INC.. Cumulatively, 7 reports have been logged. Split: 7 buys · 0 sell. Total volume traded: €919k. Activity tracked since 27 August 2026. The latest transaction was disclosed on 28 August 2026 (10 - Acquisition or disposition in the public market). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Robert Christopher Andrade is a declarant linked to Fennec Pharmaceuticals INC. as 5 - Senior Officer of Issuer. The 6 recorded filings in the recent sample run from 2026-06-04 to 2026-08-28 and concern purchases, with total buy volume of EUR 918807 and no reported sales.